Solara Active Pharma Sciences Limited has informed the exchange regarding the reappointment of Internal Auditor and Cost Auditor for the FY 2026-27.
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Solara Active Pharma Sciences has announced the re-appointment of its Internal Auditor and Cost Auditor for the financial year 2026-27. The Board approved these appointments at its meeting held on May 15, 2026. M/s. Grant Thornton Bharat LLP, a leading professional services firm, has been re-appointed as Internal Auditors. Mr. K. Suryanarayanan, a Fellow member of the Institute with over two decades of experience in Finance, Accounts, Costing, and Taxation, has been re-appointed as Cost Auditor. This filing is made under SEBI Listing Regulations as a routine compliance requirement.
This is a routine corporate governance update with no direct impact on the stock price or shareholder value. The continuation of existing auditors indicates stability in the company's audit framework.